ZA818665B - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- ZA818665B ZA818665B ZA818665A ZA818665A ZA818665B ZA 818665 B ZA818665 B ZA 818665B ZA 818665 A ZA818665 A ZA 818665A ZA 818665 A ZA818665 A ZA 818665A ZA 818665 B ZA818665 B ZA 818665B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8040081 | 1980-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA818665B true ZA818665B (en) | 1982-10-27 |
Family
ID=10517993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA818665A ZA818665B (en) | 1980-12-15 | 1981-12-14 | Therapeutic agents |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4363912A (enExample) |
| EP (1) | EP0054417B1 (enExample) |
| JP (1) | JPS57181082A (enExample) |
| KR (1) | KR830007552A (enExample) |
| AR (1) | AR229110A1 (enExample) |
| AU (1) | AU525296B2 (enExample) |
| CA (1) | CA1143737A (enExample) |
| CS (1) | CS228527B2 (enExample) |
| DD (1) | DD202290A5 (enExample) |
| DE (1) | DE3167879D1 (enExample) |
| DK (1) | DK552581A (enExample) |
| ES (1) | ES8308872A1 (enExample) |
| FI (1) | FI814003A7 (enExample) |
| GR (1) | GR76355B (enExample) |
| IE (1) | IE51949B1 (enExample) |
| IL (1) | IL64534A0 (enExample) |
| NO (1) | NO814264L (enExample) |
| PH (1) | PH17576A (enExample) |
| PL (1) | PL133634B1 (enExample) |
| PT (1) | PT74123B (enExample) |
| YU (1) | YU293481A (enExample) |
| ZA (1) | ZA818665B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| US4460777A (en) * | 1981-11-19 | 1984-07-17 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
| US4478842A (en) * | 1981-11-19 | 1984-10-23 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
| US4536505A (en) * | 1983-05-17 | 1985-08-20 | Ciba-Geigy Corporation | Certain N-(pyridyl) indoles |
| US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
| GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
| US4609733A (en) * | 1984-12-27 | 1986-09-02 | Ciba-Geigy Corporation | 3-keto-substituted-N-pyridylindoles |
| GB8609175D0 (en) * | 1986-04-15 | 1986-05-21 | Ici America Inc | Heterocyclic carboxamides |
| ATE269861T1 (de) * | 1998-03-31 | 2004-07-15 | Inst For Pharm Discovery Inc | Substituierte indolalkansäure |
| TNSN99224A1 (fr) * | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
| WO2001051489A2 (en) * | 2000-01-14 | 2001-07-19 | The Institutes For Pharmaceutical Discovery, Llc | Methods for lowering uric acid levels |
| ES2268480T3 (es) * | 2002-12-10 | 2007-03-16 | Wyeth | Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1). |
| GB0324763D0 (en) * | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| EP2046740B1 (en) | 2006-07-22 | 2012-05-23 | Oxagen Limited | Compounds having crth2 antagonist activity |
| KR20100067677A (ko) * | 2007-09-24 | 2010-06-21 | 알러간, 인코포레이티드 | 스핑고신-1-포스페이트 (ｓｐ1) 생물학적 활성을 갖는 아릴 또는 헤테로아릴 기를 함유하는 인돌 화합물 |
| AU2009204700B2 (en) * | 2008-01-18 | 2013-07-04 | Atopix Therapeutics Limited | Compounds having CRTH2 antagonist activity |
| US7750027B2 (en) * | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
| JP2011509991A (ja) * | 2008-01-22 | 2011-03-31 | オキサジェン リミテッド | Ｃｒｔｈ２アンタゴニスト活性を有する化合物 |
| WO2009093026A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
| GB201407820D0 (en) * | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407807D0 (en) * | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5173M (enExample) * | 1966-02-11 | 1967-06-19 | ||
| FR7337M (enExample) * | 1968-01-11 | 1969-10-13 | ||
| GB2045244B (en) | 1979-03-07 | 1983-01-26 | Pfizer Ltd | 3-1-(imidazolylalkyl) indoles |
| US4322533A (en) * | 1980-03-17 | 1982-03-30 | Lesher George Y | 1H-Indole-2,3-dione derivatives |
-
1981
- 1981-12-03 US US06/326,800 patent/US4363912A/en not_active Expired - Lifetime
- 1981-12-10 GR GR66766A patent/GR76355B/el unknown
- 1981-12-10 EP EP81305836A patent/EP0054417B1/en not_active Expired
- 1981-12-10 DE DE8181305836T patent/DE3167879D1/de not_active Expired
- 1981-12-11 PH PH26617A patent/PH17576A/en unknown
- 1981-12-14 AR AR287794A patent/AR229110A1/es active
- 1981-12-14 CA CA000392225A patent/CA1143737A/en not_active Expired
- 1981-12-14 DD DD81235742A patent/DD202290A5/de unknown
- 1981-12-14 IL IL64534A patent/IL64534A0/xx unknown
- 1981-12-14 IE IE2928/81A patent/IE51949B1/en unknown
- 1981-12-14 ZA ZA818665A patent/ZA818665B/xx unknown
- 1981-12-14 FI FI814003A patent/FI814003A7/fi not_active Application Discontinuation
- 1981-12-14 PT PT74123A patent/PT74123B/pt unknown
- 1981-12-14 AU AU78488/81A patent/AU525296B2/en not_active Ceased
- 1981-12-14 YU YU02934/81A patent/YU293481A/xx unknown
- 1981-12-14 ES ES507960A patent/ES8308872A1/es not_active Expired
- 1981-12-14 KR KR1019810004911A patent/KR830007552A/ko not_active Withdrawn
- 1981-12-14 JP JP56201438A patent/JPS57181082A/ja active Pending
- 1981-12-14 DK DK552581A patent/DK552581A/da not_active Application Discontinuation
- 1981-12-14 NO NO814264A patent/NO814264L/no unknown
- 1981-12-15 PL PL1981234253A patent/PL133634B1/pl unknown
- 1981-12-15 CS CS819343A patent/CS228527B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1143737A (en) | 1983-03-29 |
| DK552581A (da) | 1982-06-16 |
| PT74123A (en) | 1982-01-01 |
| AR229110A1 (es) | 1983-06-15 |
| JPS57181082A (en) | 1982-11-08 |
| FI814003L (fi) | 1982-06-16 |
| IL64534A0 (en) | 1982-03-31 |
| NO814264L (no) | 1982-06-16 |
| PH17576A (en) | 1984-10-01 |
| FI814003A7 (fi) | 1982-06-16 |
| ES507960A0 (es) | 1983-10-01 |
| AU525296B2 (en) | 1982-10-28 |
| CS228527B2 (en) | 1984-05-14 |
| PL133634B1 (en) | 1985-06-29 |
| EP0054417A1 (en) | 1982-06-23 |
| IE51949B1 (en) | 1987-04-29 |
| EP0054417B1 (en) | 1984-12-19 |
| US4363912A (en) | 1982-12-14 |
| PL234253A1 (en) | 1983-05-23 |
| DD202290A5 (de) | 1983-09-07 |
| DE3167879D1 (en) | 1985-01-31 |
| AU7848881A (en) | 1982-06-24 |
| YU293481A (en) | 1984-10-31 |
| GR76355B (enExample) | 1984-08-06 |
| KR830007552A (ko) | 1983-10-21 |
| PT74123B (en) | 1983-12-19 |
| ES8308872A1 (es) | 1983-10-01 |
| IE812928L (en) | 1982-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2098602B (en) | Therapeutic agents | |
| ZA821577B (en) | Therapeutic agents | |
| ZA818665B (en) | Therapeutic agents | |
| DE3165786D1 (en) | Imidazolylpyridine therapeutic agents | |
| ZA828453B (en) | Therapeutic agents | |
| EG16991A (en) | Therapeutic agents | |
| ZA81715B (en) | Antirhinovirus agents | |
| IL63845A0 (en) | Therapeutic agents | |
| GB2085441B (en) | Therapeutic agents | |
| EP0051789A3 (en) | Therapeutic composition | |
| JPS56125047A (en) | Massager | |
| JPS56130153A (en) | Massager | |
| ZA836848B (en) | Therapeutic agents | |
| JPS5717655A (en) | Massager | |
| JPS56104661A (en) | Massager | |
| ZA816352B (en) | Therapeutic agents | |
| JPS57112868A (en) | Massager | |
| JPS56125046A (en) | Massager | |
| JPS56125054A (en) | Massager | |
| JPS56152649A (en) | Massager | |
| ZW22481A1 (en) | Therapeutic agents | |
| JPS5722753A (en) | Massager | |
| JPS56125052A (en) | Massager | |
| JPS56151048A (en) | Massager | |
| IE801360L (en) | Therapeutic combinations |